Patient 4:
A 42-year-old active smoker with no known past medical history. 2-days after being hospitalized for moderate COVID-19 moderate pneumonia and after receiving hydroxychloroquine, azithromycin, enoxaparin, methylprednisolone plus ritonavir/ lopinavir; he developed a left-sided body weakness with facial asymmetry and slurring of speech of unknown time of onset associated with a sudden decrease in the level of consciousness with NIHSS- 9. A CT-scan brain with perfusion and C.T. angiography showed a large area of matched perfusion defect noted in the right MCA territory with infarction involving the right front-temporoparietal region and a filling defect in the distal segment of the right common carotid artery at its bifurcation. We did not offer thrombolysis as the time of stroke onset was unclear. He was managed conservatively with IV heparin, then changed to antiplatelets and a rehabilitation program for the body weakness.